Pivotal bioVenture Partners Investment Advisor LLC

Q4 2020 13F Holdings Report, Stock Holdings

Signature - Title
Robert Hopfner - Managing Partner
Location
San Francisco, CA
Holdings as of
31 Dec 2020
Value $
$303,302,000
Num holdings
9
Filing time
09 Feb 2021, 16:50:30 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included KRTX, PCVX, AKUS, INZY, and ALGS.
Next filing
Q1 2021 - 14 May 2021
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Robert Hopfner Managing Partner San Francisco, California 09 Feb 2021

Other Included Managers (1):

Num Name Location File Number
1 Pivotal bioVenture Partners Fund I U.G.P. Ltd San Francisco, CA